JP2001520998A5 - - Google Patents

Download PDF

Info

Publication number
JP2001520998A5
JP2001520998A5 JP2000517717A JP2000517717A JP2001520998A5 JP 2001520998 A5 JP2001520998 A5 JP 2001520998A5 JP 2000517717 A JP2000517717 A JP 2000517717A JP 2000517717 A JP2000517717 A JP 2000517717A JP 2001520998 A5 JP2001520998 A5 JP 2001520998A5
Authority
JP
Japan
Prior art keywords
compound according
spla
compound
dioxoethyl
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000517717A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001520998A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/022679 external-priority patent/WO1999021559A1/en
Publication of JP2001520998A publication Critical patent/JP2001520998A/ja
Publication of JP2001520998A5 publication Critical patent/JP2001520998A5/ja
Withdrawn legal-status Critical Current

Links

JP2000517717A 1997-10-27 1998-10-26 インドールsPLA2阻害剤のモルホリノ−N−エチルエステルプロドラッグ Withdrawn JP2001520998A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6364697P 1997-10-27 1997-10-27
US60/063,646 1997-10-27
PCT/US1998/022679 WO1999021559A1 (en) 1997-10-27 1998-10-26 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS

Publications (2)

Publication Number Publication Date
JP2001520998A JP2001520998A (ja) 2001-11-06
JP2001520998A5 true JP2001520998A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=22050578

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000517717A Withdrawn JP2001520998A (ja) 1997-10-27 1998-10-26 インドールsPLA2阻害剤のモルホリノ−N−エチルエステルプロドラッグ

Country Status (9)

Country Link
US (1) US6177426B1 (cg-RX-API-DMAC7.html)
EP (1) EP1039911B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001520998A (cg-RX-API-DMAC7.html)
AT (1) ATE296286T1 (cg-RX-API-DMAC7.html)
AU (1) AU1200899A (cg-RX-API-DMAC7.html)
CA (1) CA2308443A1 (cg-RX-API-DMAC7.html)
DE (1) DE69830335T2 (cg-RX-API-DMAC7.html)
ES (1) ES2241178T3 (cg-RX-API-DMAC7.html)
WO (1) WO1999021559A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1200899A (en) 1997-10-27 1999-05-17 Eli Lilly And Company Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors
US6274578B1 (en) 1999-04-20 2001-08-14 Eli Lilly And Company sPLA2 inhibitor ester
US6140327A (en) * 1999-05-12 2000-10-31 Eli Lilly And Company Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
DE60032774D1 (de) * 1999-07-19 2007-02-15 Lilly Co Eli Spla2 inhibitoren
US6706752B1 (en) 1999-07-19 2004-03-16 Eli Lilly And Company sPLA2 inhibitors
US6831095B1 (en) 1999-09-20 2004-12-14 Eli Lilly And Company Hydroxyfunctional amide 1h-indole derivatives active as sPLA2 inhibitors
WO2001021587A2 (en) * 1999-09-20 2001-03-29 Eli Lilly And Company Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
CN1450893A (zh) * 2000-07-14 2003-10-22 伊莱利利公司 治疗脓毒症的方法
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
US9597292B2 (en) 2012-08-22 2017-03-21 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
EP2887934A1 (en) 2012-08-22 2015-07-01 XenoPort, Inc. Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
US9421182B2 (en) 2013-06-21 2016-08-23 Xenoport, Inc. Cocrystals of dimethyl fumarate
JP2016534133A (ja) 2013-09-06 2016-11-04 ゼノポート,インコーポレイティド (n,n−ジエチルカルバモイル)メチル メチル(2e)ブト−2−エン−1,4−ジオエートの結晶形態、その合成方法及び使用
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20160198B1 (ar) * 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
WO2017167953A1 (en) 2016-03-31 2017-10-05 Janssen Pharmaceuticals, Inc. Substituted indoline derivatives as dengue viral replication inhibitors
JOP20170069B1 (ar) 2016-04-01 2021-08-17 1 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar) 2017-03-31 2021-08-17 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180026A1 (ar) 2017-03-31 2019-01-30 Univ Leuven Kath مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
CA3060583C (en) 2017-05-22 2024-06-04 Janssen Pharmaceuticals, Inc. Substituted indoline derivatives as dengue viral replication inhibitors
CR20190531A (es) 2017-05-22 2020-03-05 Janssen Pharmaceuticals Inc Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
PH12022551160A1 (en) 2019-11-15 2023-09-25 Janssen Pharmaceuticals Inc Treatment and prevention of dengue disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1950200B1 (en) 1994-04-01 2012-01-11 Eli Lilly And Company [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor
US5972988A (en) 1997-03-26 1999-10-26 Eli Lilly And Company Method for treatment of chronic bronchitis using indole compounds
WO1999021545A1 (en) * 1997-10-27 1999-05-06 Eli Lilly And Company ISOPROPYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS
AU1200899A (en) 1997-10-27 1999-05-17 Eli Lilly And Company Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors
EP1039901A1 (en) 1997-11-14 2000-10-04 Eli Lilly And Company Treatment for alzheimer's disease

Similar Documents

Publication Publication Date Title
DK1950200T3 (da) [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-(PHENYLMETHYL)-11H-INDOL-4-YL]OXY]EDDIKESYREMETHYLESTER SOM sPLA2-INHIBITOR
JP2002518502A5 (cg-RX-API-DMAC7.html)
CA2445145A1 (en) Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
DE69924869D1 (de) Medikament zur behandlung chronisch obstruktiver lungenerkrankung
WO1999047497A3 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
AU1200899A (en) Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors
CA2382098A1 (en) Sustained-release, oral pharmaceutical forms of administration
CA2474904A1 (en) Once-a-day oxycodone formulations
AU4327300A (en) Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension
JP2003503449A5 (cg-RX-API-DMAC7.html)
JP2002509153A5 (cg-RX-API-DMAC7.html)
JP2002502836A5 (cg-RX-API-DMAC7.html)
JP2001520991A5 (cg-RX-API-DMAC7.html)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2005539045A5 (cg-RX-API-DMAC7.html)
WO2001019814A3 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
JP2002520286A5 (cg-RX-API-DMAC7.html)
JP2002513761A5 (cg-RX-API-DMAC7.html)
JP2005513014A5 (cg-RX-API-DMAC7.html)
JP2004537498A5 (cg-RX-API-DMAC7.html)
JP2002506864A5 (cg-RX-API-DMAC7.html)
IL146197A0 (en) Process for the preparation of carboxylic acid salts from primary alcohols
WO2001019819A3 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
JPH1036365A5 (cg-RX-API-DMAC7.html)
AU2001242376A1 (en) Process for the preparation of 2-hydroxy-4-methylthiobutyric acid esters